Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02172820 · ClinicalTrials.gov registry record · NA

Increasing Cardiac Rehabilitation Participation Among Medicaid Enrollees

A NA study, sponsored by University of Vermont.

Completed
Registry status
NA
Development phase
130
Enrollment target

NCT02172820 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 130 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02172820, a NA study, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target

Study Summary

Participation in outpatient cardiac rehabilitation (CR) decreases morbidity and mortality for patients hospitalized with myocardial infarction, coronary bypass surgery or percutaneous revascularization. Unfortunately, only 10-35% of patients for whom CR is indicated choose to participate. Medicaid coverage and similar state-supported insurance are robust predictors of CR non-participation. There is growing recognition of the need to increase CR among patients with this form of insurance and other economically disadvantaged patients, but there are no evidence-based interventions available for doing so. In the present study we are examining the efficacy of using financial incentives for increasing CR participation among Medicaid patients. Financial incentives have been highly effective in altering other health behaviors among disadvantaged populations (e.g., smoking during pregnancy, weight loss). For this study are randomizing 130 CR-eligible Medicaid enrollees to a treatment condition where they receive financial incentives contingent on initiation of and continued attendance at CR sessions or to a "usual-care" condition where they will not receive these incentives. Treatment conditions will be compared on attendance at CR and end-of-intervention improvements in fitness, decision making and health-related quality of life. Cost effectiveness of the treatment conditions will also be examined by comparing the costs of the incentive intervention and usual care conditions with their effects on increasing CR initiation and adherence. Should this intervention be efficacious and cost-effective, it has the potential to substantially increase CR participation and significantly improve health outcomes among low-income cardiac patients.

Interventions

  • BEHAVIORAL Financial incentives

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2014-04
Est. Completion 2018-02
Phase NA

Sponsor

University of Vermont

162 total trials

What the Registry Record Tells You About NCT02172820

The ClinicalTrials.gov registry entry for NCT02172820 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Financial incentives is the first listed.

NCT02172820 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02172820 about?

NCT02172820 is a clinical study titled "Increasing Cardiac Rehabilitation Participation Among Medicaid Enrollees". Participation in outpatient cardiac rehabilitation (CR) decreases morbidity and mortality for patients hospitalized with myocardial infarction, coronary bypass surgery or percutaneous revascularization. Unfortunately, only 10-35% of patients for whom CR is indicated choose to participate. Medicaid c...

What is the current status of trial NCT02172820?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2014-04. Estimated completion is 2018-02.

What interventions are being tested in trial NCT02172820?

The interventions under investigation include: Financial incentives (BEHAVIORAL).

Who is sponsoring clinical trial NCT02172820?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.